Abstract: A chlorine dioxide-containing composition comprising sodium chlorite; an initiator selected from the group consisting of (A) a thickening agent; (B) a colorant, (C) a perfume and mixtures thereof; chlorine dioxide at an antimicrobial concentration, and water, the sodium chlorite and the initiator being present in the composition in an amount adapted to form interactively said antimicrobial chlorine oxide concentration, said composition having a viscosity suitable to maintain the thus-formed chlorine dioxide at a steady-state concentration.

Abstract: The invention encompasses the use of nitroaminobenzaldehydes and nitroaminobenzylimines as hair dyeing agents.

Abstract: An acidic, aqueous cleaning composition comprising a surfactant; up to about 50% of a higher boiling solvent, typically in alkyl ether of an alkylene glycol, said solvent introducing impurities into the composition in an amount and of a nature normally chemically incompatible with oxidizable dye chromophores; a dye in an amount to provide a desired tinctorial value, and oxalic acid or a salt thereof in an amount effective to retard fading of the dye. In another aspect of the invention, the oxalic acid incorporated into compositions containing a solvent, a surfactant, and water, and optionally a dye provides a beneficial cleaning result. In yet another aspect of the invention, the oxalic acid beneficially retards the development of malodors when the compositions of the present invention are contained in a PVC container. Broadly, the incorporation of oxalic acid in said solvent can be employed to neutralize said impurities.

Abstract: Prepares aluminum chlorhydroxide product high in molecular species content having a K.sub.d value equal to 0.4 by heating a 5% aqueous solution of aluminum chlorhydroxide at a temperature in the range of from about 100.degree. to about 132.degree. for a period of about 30 minutes to about three months and then spray drying the product, the heating preferably being done under pressure.

Abstract: An aqueous cleaning composition comprising a surfactant; up to about 50% of a higher boiling solvent, typically an alkyl ether of an alkylene glycol, said solvent introducing impurities into the composition in an amount and of a nature normally chemically incompatible with oxidizable dye chromophores; a dye in an amount to provide a desired tinctorial value, and a stabilizer selected from the group consisting of salts suitable to provide iodide and thiosulfate anions in an amount effective to retard fading of the dye, said compositions having a basic pH when the stabilizer is the thiousulfate salt. In another aspect of the invention, the stabilizer incorporated into compositions containing a solvent, a surfactant, and water, and optionally a dye provides a beneficial cleaning result. In yet another aspect of the invention, the stabilizer beneficially retards the development of malodors when the compositions of the present invention are contained in a PVC container.

Abstract: Novel sulfur containing nitroamino benzene dyes of formula: ##STR1## and salts thereof wherein (a) R.sub.1 and R.sub.2 are the same or different and are selected from the group consisting of alkyl, hydroxyalkyl, polyhydroxyalky, aminoalkyl, monoalkylamioalkyl and dialkylaminoalkyl,wherein(b) n is 0, 1 or 2, and wherein(c) the group ##STR2## occupies a position that is meta or para to the group-NHR.sub.1 ; a process for synthesizing these compounds and their use as direct dyeing hair dyes are being disclosed.

Abstract: A method and apparatus for artificially bleaching or lightening hair by exposing the hair to intense radiation of artificial light. The light is typically from a laser or flashlamp source and provides adequate intensity and power during the lifetime of the excited melanin molecule in the hair to substantially destroy at least some of the melanin molecules in the hair.

Abstract: The invention relates to an oral pharmaceutical composition containing benzonatate. More particularly it concerns a composition of this character having improved taste and demulcency characteristics as well as one which minimizes the local anaesthesia to the oral muscosa brought about by the benzonatate.

Abstract: An antiperspirant composition buffered to a pH in the range of from about 2.5 to about 4.5 having incorporated therein as active ingredients a combination of aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex; an additionally added buffering agent, preferably glycine, may be incorporated in the composition.

Abstract: Certain derivatives of procaterol are believed to possess similar biological activity to the base compound, (i.e., as bronchodilators) but have greater stability and bioavailability.

Abstract: Quaternary ammonium salts of furosemide are stable and highly water-soluble, affording thereby solid oral dosage forms which are more bioavailable, oral liquid dosage forms hitherto unavailable, and injectable dosage forms of furosemide with higher concentration, hence lower volume, which do not add to the sodium ion burden of patients to whom it may be administered.

Abstract: Cyclodextrin clathrates of certain unsaturated phosphorous containing antibiotics exhibit enhanced stability in pharmaceutical compositions.

Abstract: The natural 3S, 4S isomer of the protected amino acid Boc-statine can be efficiently produced in large quantities using a novel method.

Abstract: Useful parenteral phenytoin preparations can be made using certain complexes of phenytoin or phenytoin sodium.

Abstract: Procaterol, and pharmaceutically active forms thereof, can be rendered resistant to attack by moisture and air via reaction with certain stabilizing reagents.

Abstract: A clear gel and a cream pharmaceutical composition containing meclofenamic acid are disclosed. The clear gel composition is prepared by dissolving meclofenamic acid in polyethylene glycol monolaurate and polyethylene glycol lanolin oil and adding isopropyl alcohol with mixing and finally adding colloidal silicon dioxide with mixing. The cream composition is prepared by adding meclofenamic acid or the sodium salt thereof to an emulsion prepared by mixing a warm aqueous solution of sorbic acid with a melt of polyethylene glycol monostearate, glyceryl monostearate, caprylic and capric triglyceride and mineral oil.The resulting compositions are indicated for the treatment of inflammation.

Abstract: The problems of tackiness and long curing times usually associated with the treatment of dosage forms are overcome via the use of a new curing process. That process involves: (1) coating a drug with a sustained release formulation, (2) immediately coating with a water-soluble overcoat, (3) drying, and (4) recovering the coated dosage form.

Abstract: A non-steroidal anti-inflammatory composition comprising a therapeutically effective amount of active anti-inflammatory agent selected from the group consisting of 1-phenyl-1 cyclohexene, 4-phenylcyclohexanone, and mixtures thereof. The active agent may be formulated in a pharmaceutically acceptable carrier. These compositions are useful in the treatment in mammals of inflammation and other related symptoms, including pain.

Abstract: A non-steroidal anti-inflammatory composition comprising an active anti-inflammatory agent having the formula: ##STR1## The active agent is formulated with a pharmaceutically acceptable carrier for use in the treatment of pain, inflammation and other related symptoms on mammals.

Abstract: A non-steroidal anti-inflammatory composition comprising an active anti-inflammatory agent having the formula: ##STR1## The active agent is formulated with a pharmaceutically acceptable carrier for use in the treatment of pain, inflammation and other related symptoms on mammals.